Fidelity Investments’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Fidelity Investments’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	–	–	4464
2019 Q4	$0	Buy	+1	New	+$22	﹤0.01%	4427

Other funds holding LDRS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments's LDRS Position: Q1 2020 in Review

Fidelity Investments sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q1 2020, closing a stake of 1 share.

Fidelity Investments first reported a position in LDRS in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 8 funds tracked by Wall St. Rank hold LDRS as of Q1 2020.

Fidelity Investments reported no remaining Innovator IBD ETF Leaders ETF position as of Q1 2020 after selling out during the quarter.
Fidelity Investments sold 1 Innovator IBD ETF Leaders ETF share in Q1 2020.
Fidelity Investments first reported a position in Innovator IBD ETF Leaders ETF in Q4 2019 and held it in 1 quarter.
Fidelity Investments's Innovator IBD ETF Leaders ETF position peaked at $0 in Q4 2019.
8 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q1 2020.

Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.